Ligand Pharmaceuticals Inc (LGND)-Financial and Strategic SWOT Analysis Review

Ligand Pharmaceuticals Inc (LGND)-Financial and Strategic SWOT Analysis Review


  • Products Id :- GDPH59641FSA
  • |
  • Pages: 65
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Ligand Pharmaceuticals Inc (LGND)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company's operations and business divisions.

Corporate strategy-Analyst's summarization of the company's business strategy.

SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Key manufacturing facilities-A list of key manufacturing facilities of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help in discovery and development of medicines. The company provides a diversified portfolio of biotechnology and pharmaceutical products. Its marketed product portfolio encompasses indication for fungal infections, hepatitis C, Idiopathic thrombocytopenic purpura (ITP), multiple myeloma, cancer, osteoporosis, and severe aplastic anemia. Ligand's clinical development portfolio comprises medications targeted at the treatment of seizure, cancer, diabetes, coma, cardiovascular disease, liver disease, muscle wasting, kidney disease, and others. In partnership with other pharmaceutical companies the company also offers late-stage development, regulatory management and commercialization support. Ligand is headquartered in San Diego, California, the US.

Ligand Pharmaceuticals Inc Key Recent Developments

May 09,2017: Ligand Reports First Quarter 2017 Financial Results

Feb 28,2017: Ligand Provides Highlights From Analyst Day Event

Feb 23,2017: Ligand Reports Fourth Quarter and Full Year 2016 Financial Results

Feb 14,2017: Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform

Nov 03,2016: Ligand Reports Third Quarter 2016 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Ligand Pharmaceuticals Inc-Key Facts 6

Ligand Pharmaceuticals Inc-Key Employees 7

Ligand Pharmaceuticals Inc-Key Employee Biographies 8

Ligand Pharmaceuticals Inc-Major Products and Services 9

Ligand Pharmaceuticals Inc-Pharmaceutical Pipeline Products Data 13

Ligand Pharmaceuticals Inc, Pipeline Products by Therapy Area 13

Ligand Pharmaceuticals Inc, Pipeline Products by Development Phase 14

Ligand Pharmaceuticals Inc-History 15

Ligand Pharmaceuticals Inc-Company Statement 20

Ligand Pharmaceuticals Inc-Locations And Subsidiaries 21

Head Office 21

Other Locations & Subsidiaries 21

Section 2-Company Analysis 23

Ligand Pharmaceuticals Inc-Business Description 23

Ligand Pharmaceuticals Inc-Corporate Strategy 24

Ligand Pharmaceuticals Inc-SWOT Analysis 25

SWOT Analysis-Overview 25

Ligand Pharmaceuticals Inc-Strengths 25

Ligand Pharmaceuticals Inc-Weaknesses 26

Ligand Pharmaceuticals Inc-Opportunities 27

Ligand Pharmaceuticals Inc-Threats 28

Ligand Pharmaceuticals Inc-Key Competitors 29

Section 3-Company Financial Ratios 30

Financial Ratios-Capital Market Ratios 30

Financial Ratios-Annual Ratios 31

Performance Chart 34

Financial Performance 34

Financial Ratios-Interim Ratios 35

Financial Ratios-Ratio Charts 36

Section 4-Company's Lifesciences Financial Deals and Alliances 37

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 37

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 38

Ligand Pharmaceuticals Inc, Recent Deals Summary 39

Section 5-Company's Recent Developments 40

May 09, 2017: Ligand Reports First Quarter 2017 Financial Results 40

Feb 28, 2017: Ligand Provides Highlights From Analyst Day Event 43

Feb 23, 2017: Ligand Reports Fourth Quarter and Full Year 2016 Financial Results 45

Feb 14, 2017: Dr. Christel Iffland Joins Ligand as Vice President, Antibody Technologies, Expands Team Focused on OmniAb Drug Discovery Platform 48

Nov 03, 2016: Ligand Reports Third Quarter 2016 Financial Results 49

Aug 04, 2016: Ligand Reports Second Quarter 2016 Financial Results 52

May 04, 2016: Ligand Reports First Quarter 2016 Financial Results 55

Feb 10, 2016: Ligand Reports Fourth Quarter and Full Year 2015 Financial Results 58

Section 6-Appendix 61

Methodology 61

Ratio Definitions 61

About GlobalData 65

Contact Us 65

Disclaimer 65

List of Figures

Ligand Pharmaceuticals Inc, Pipeline Products by Therapy Area 13

Ligand Pharmaceuticals Inc, Pipeline Products by Development Phase 14

Ligand Pharmaceuticals Inc, Performance Chart (2012-2016) 34

Ligand Pharmaceuticals Inc, Ratio Charts 36

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 37

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 38

List of Tables

Ligand Pharmaceuticals Inc, Key Facts 6

Ligand Pharmaceuticals Inc, Key Employees 7

Ligand Pharmaceuticals Inc, Key Employee Biographies 8

Ligand Pharmaceuticals Inc, Major Products and Services 9

Ligand Pharmaceuticals Inc, Number of Pipeline Products by Therapy Area 13

Ligand Pharmaceuticals Inc, Number of Pipeline Products by Development Stage 14

Ligand Pharmaceuticals Inc, History 15

Ligand Pharmaceuticals Inc, Subsidiaries 21

Ligand Pharmaceuticals Inc, Key Competitors 29

Ligand Pharmaceuticals Inc, Ratios based on current share price 30

Ligand Pharmaceuticals Inc, Annual Ratios 31

Ligand Pharmaceuticals Inc, Annual Ratios (Cont...1) 32

Ligand Pharmaceuticals Inc, Annual Ratios (Cont...2) 33

Ligand Pharmaceuticals Inc, Interim Ratios 35

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 37

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 38

Ligand Pharmaceuticals Inc, Recent Deals Summary 39

Currency Codes 61

Capital Market Ratios 61

Equity Ratios 62

Profitability Ratios 62

Cost Ratios 63

Liquidity Ratios 63

Leverage Ratios 64

Efficiency Ratios 64

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to query [@] kenresearch.com
 

Ligand Pharmaceuticals Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts

select a license

Single User License
USD 125 INR 8044
Site License
USD 250 INR 16088
Corporate User License
USD 375 INR 24131

NEWSLETTER BY CATEGORY




Testimonials

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

I am pleased to see the very useful and productive information in the report..Very well structured great presentation reflect professionalism in your research studies....

While we still are studying and analysing your reports about Vietnam & Thailand, we would like to convey to your research team that they have done a very good job in compiling so much of information together. We hope to see more of such well researched reports. All the best & keep it up. ...

We would like to appreciate Ken Research for their great efforts and wonderful support in providing the Market Intelligence Report for ITPC. The information, statistics and research are well understandable and very clear to the point. We are happy with Ken research for their good client service, on-time delivery of the report and as said the report itself. Thank you Ken research for bringing the valuable output for us. We would be looking forward to have more research with you in the near future. Wish you a success in your business!...



Related Products in vertical
Ken Research Pvt. Ltd. Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

query [@] kenresearch.com